Deborah G. A. Peeters

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The aim of therapeutic dendritic cell (DC) vaccines in cancer immunotherapy is to activate cytotoxic T cells to recognize and attack the tumor. T cell activation requires the interaction of the T cell receptor with a cognate major-histocompatibility complex-peptide complex. Although initiated by antigen engagement, it is the complex balance between(More)
  • 1